Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
ZIVO Bioscience, Inc. (ZIVO) had Consolidated Net Income/Loss of $-0.51M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.51M |
|
-- |
|
-- |
|
$0.51M |
|
$-0.51M |
|
$-0.00M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
|
Consolidated Net Income/Loss |
$-0.51M |
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
4.15M |
|
4.15M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$0.39M |
|
-- |
|
$0.05M |
|
$0.44M |
|
$3.81M |
|
-- |
|
$0.02M |
|
$3.83M |
|
$-3.38M |
|
$-3.38M |
|
$-3.38M |
|
4.21M |
|
| Cash Flow Statement Financials | |
$-1.11M |
|
-- |
|
$1.15M |
|
$0.07M |
|
$0.11M |
|
$0.05M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-- |
|
-0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
15.15% |
|
15.15% |
|
-115.56% |
|
15.15% |
|
$-0.80 |
|
$-0.27 |
|
$-0.27 |
|